✦ LIBER ✦
Erythropoiesis-Stimulating Agent Use Among Non–Dialysis-Dependent CKD Patients Before and After the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Using a Large US Health Plan Database
✍ Scribed by Thamer, Mae; Zhang, Yi; Kshirsagar, Onkar; Cotter, Dennis J.; Kaufman, James S.
- Book ID
- 126286305
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 933 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0272-6386
No coin nor oath required. For personal study only.